Inhibitor compounds of phosphodiesterase type 10A

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 9200005
APP PUB NO 20140275069A1
SERIAL NO

14189961

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

The present invention relates to compounds of the formula I, the N-oxides, tautomers, the prodrugs and the pharmaceutically acceptable salts thereof:

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
ABBVIE DEUTSCHLAND GMBH & CO KGMAINZER STR 81 WIESBADEN 65189

International Classification(s)

  • [Classification Symbol]
  • [Patents Count]

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Dinges, Jürgen North Chicago, US 17 80
Drescher, Karla Ludwigshafen, DE 77 254
Froggett, Jayne Ludwigshafen, DE 4 45
Geneste, Hervé Ludwigshafen, DE 44 243
Jakob, Clarissa North Chicago, US 14 76
Jantos, Katja Ludwigshafen, DE 37 158
Ochse, Michael Ludwigshafen, DE 53 631

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation

Maintenance Fees

Fee Large entity fee small entity fee micro entity fee due date
11.5 Year Payment $7400.00 $3700.00 $1850.00 Jun 1, 2027
Fee Large entity fee small entity fee micro entity fee
Surcharge - 11.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge after expiration - Late payment is unavoidable $700.00 $350.00 $175.00
Surcharge after expiration - Late payment is unintentional $1,640.00 $820.00 $410.00